共 50 条
- [21] EFFICACY OF THE COMBINATION OF BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIAHAEMATOLOGICA, 2014, 99 : 591 - 591Zagoskina, T.Zotina, E.Ovsepyan, V.Shardakov, V.
- [22] Impact of High Risk Prognostic Parameters and Addition of Ibrutinib to Bendamustine/Rituximab (BR) on Outcomes for Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the Phase 3 Double-Blind HELIOS TrialBLOOD, 2015, 126 (23)Chanan-Khan, AsherCramer, PaulaFraser, GraemeSilva, Rodrigo SantucciGrosicki, SebastianPristupa, AleksanderDilhuydy, Marie SarahGoy, AndreMato, Anthony R.Damle, RajendraPhelps, CharlesMahler, MichelleSalman, MariyaSchaffer, MichaelHowes, AngelaBalasubramanian, Sriram
- [23] Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): safety analysis in the HELIOS trialLEUKEMIA & LYMPHOMA, 2015, 56 : 93 - 94Cramer, PaulaChanan-Khan, AsherFraser, GraemeDemirkan, FatihSilva, Rodrigo SantucciPylypenko, HalynaGrosicki, SebastianJanssens, AnnPristupa, AleksanderGoy, AndreMayer, JiriDilhuydy, Marie-SarahLoscertales, JavierBarlett, NancyAvigdor, AbrahamRule, SimonSun, StevenPhelps, CharlesMahler, MichelleSalman, MashaHowes, AngelaHallek, Michael
- [24] Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic LeukemiaBLOOD, 2014, 124 (21)Gladstone, DouglasAndre, MarcJan ZauchaAssouline, SaritBellam, NareshCascavilla, NicoleJourdan, EricPanwalkar, AmitPatti, CaterinaSchulte, ClemensZaja, FrancescoGoswami, TrishnaElgeioushi, NairouzStreicher, KatieBao, HaifengSpaner, David
- [25] Bendamustine plus rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: AWisconsin Oncology Network StudyBRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (02) : 283 - 291Chang, Julie E.Havighurst, ThomasKim, KyungMannEickhoff, JensTraynor, Anne M.Kirby-Slimp, RachelVolk, Lynn M.Werndli, JaeGo, Ronald S.Weiss, MatthiasBlank, JulesKahl, Brad S.
- [26] Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study GroupJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3559 - 3566Fischer, KirstenCramer, PaulaBusch, RaymondeStilgenbauer, StephanBahlo, JasminSchweighofer, Carmen D.Boettcher, SebastianStaib, PeterKiehl, MichaelEckart, Michael J.Kranz, GabrieleGoede, ValentinElter, ThomasBuehler, AndreasWinkler, DirkKneba, MichaelDoehner, HartmutEichhorst, Barbara F.Hallek, MichaelWendtner, Clemens-Martin
- [27] Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS studyLEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2075 - 2084Cramer, PaulaFraser, GraemeSantucci-Silva, RodrigoGrosicki, SebastianDilhuydy, Marie-SarahJanssens, AnnLoscertales, JavierRule, SimonGoy, AndreTraina, ShanaChan, Eric K. H.Diels, JorisSengupta, NishanMahler, MichelleSalman, MariyaHowes, AngelaChanan-Khan, Asher
- [28] Comparing Single-Agent Ibrutinib, Bendamustine Plus Rituximab (BR) and Ibrutinib Plus BR in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): An Indirect Comparison of the RESONATE and HELIOS TrialsBLOOD, 2015, 126 (23)Hillmen, PeterFraser, GraemeJones, JeffreyRule, SimonO'Brien, SusanDilhuydy, Marie SarahJaeger, UlrichGrosicki, SebastianCymbalista, FlorenceSun, StevenNinomoto, JoiMahler, MichelleCheng, MeiDiels, JorisClow, FongSalman, MariyaJames, Danelle F.Howes, AngelaChanan-Khan, Asher
- [29] Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): subgroup efficacy analyses from the HELIOS trialLEUKEMIA & LYMPHOMA, 2015, 56 : 98 - 100Fraser, GraemeChanan-Khan, AsherCramer, PaulaDemirkan, FatihSilva, Rodrigo SantucciPylypenko, HalynaGrosicki, SebastianJanssens, AnnPristupa, AleksanderGoy, AndreMayer, JiriDilhuydy, Marie-SarahLoscertales, JavierBartlett, NancyAvigdor, AbrahamRule, SimonSun, StevenPhelps, CharlesMahler, MichelleSalman, MashaHowes, AngelaHallek, Michael
- [30] Venetoclax Plus Rituximab Is Superior to Bendamustine Plus Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia - Results from Pre-Planned Interim Analysis of the Randomized Phase 3 Murano StudyBLOOD, 2017, 130Seymour, John F.Kipps, Thomas J.Eichhorst, Barbara F.Hillmen, PeterD'Rozario, James M.Assouline, SaritOwen, Carolyn JaneGerecitano, JohnRobak, TadeuszDe la Serna, JavierJaeger, UlrichCartron, GuillaumeMontillo, MarcoHumerickhouse, RodPunnoose, ElizabethLi, YanBoyer, MichelleHumphrey, KathrynMobasher, MehrdadKater, Arnon P.